evan yu, md, elaborates on the results from keynote 365 in mcrpc
Published 5 years ago • 62 plays • Length 2:58
Download video MP4
Download video MP3
Similar videos
-
2:18
evan yu, md, regarding combination pembrolizumab and olaparib in mcrpc
-
1:29
evan yu, md, on combining checkpoint inhibitors in metastatic castration-resistant prostate cancer
-
50:29
treatments for advanced prostate cancer in 2022 | evan yu, md | pcri
-
2:03
key takeaways from keynote-365 in metastatic castration-resistant prostate cancer
-
1:10
dr. yu on the future of castration-sensitive prostate cancer
-
4:41
immunotherapy's role in prostate cancer | evan yu, md & mark moyad, md, mph | pcri 2020
-
1:26
nicholas vogelzang, md, fasco, facp, offers his impression of keynote 365 in mcrpc
-
44:59
winship grand rounds: august 23, 2023 - david yu, md, phd
-
10:55
treating high-risk gleason 8: a modern approach | mark scholz, md | pcri
-
1:32:10
six stories: a celebration of men with advanced prostate cancer
-
38:46
evan you on vue.js: seeking the balance in framework design | jsconf.asia 2019
-
2:38
keynote-365 cohort a: pembrolizumab plus olaparib in docetaxel-pretreated patients with mcrpc
-
11:50
prostate cancer: optimizing the use of newer agents - dr. evan yu, part 1
-
0:45
sumit k. subudhi, md, phd, considers the outcomes of the keynote 365 study
-
6:34
asco22 prostate cancer updates | evan yu, md | seattle cancer care alliance
-
46:19
binaytara foundation_ dr. evan yu's talk on metastatic prostate cancer
-
2:28
dr. yu on treatment intensification in metastatic castration-sensitive prostate cancer
-
0:36
active surveillance for prostate cancer
-
11:50
prostate cancer: optimizing the use of newer agents - dr. evan yu, part 2
-
58:40
winship grand rounds: may 31, 2023 - shiao-pei weathers, md
-
11:50
prostate cancer: optimizing the use of newer agents - dr. evan yu, part 3
-
1:56
our heroes: mignon loh, md
Clip.africa.com - Privacy-policy